Images List Premium Download Classic

Hypertension

Hypertension-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Treprostinil derivative compounds and methods of using same
Corsair Pharma Inc.
June 14, 2018 - N°20180162829

Compounds represented by formulae i, ii, iii, and iv including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (ph) or pulmonary arterial hypertension (pah).
Method of treating proteinuria in pregnancy
Curemark, Llc
June 14, 2018 - N°20180161409

A therapeutic agent for the treatment of toxemia, preeclampsia and eclampsia and a method for preparing the therapeutic agent are disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive/pancreatic enzymes.
Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
Ocera Therapeutics, Inc.
June 14, 2018 - N°20180161293

Disclosed herein are methods of treating and/or preventing portal hypertension and/or restoring liver function using l-ornithine phenylacetate.. .
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Therapeutic agent and therapeutic method for pulmonary hypertension
Kyowa Hakko Kirin Co., Ltd.
June 07, 2018 - N°20180155434

The present invention relates to a therapeutic agent for pulmonary hypertension comprising an interleukin-5 receptor (hereinafter, abbreviated to “il-5r”)-inhibiting compound and therapeutic method therefor. More specifically, the present invention relates to a therapeutic agent for pulmonary hypertension comprising an antibody or an antibody fragment capable of specifically binding to the extracellular region of il-5...
Application of high-intensity focused ultrasound system to treatment of essential hypertension
Nanjing Khons Medtech Co., Ltd.
June 07, 2018 - N°20180154184

An application of a high-intensity focused ultrasound system to treatment of essential hypertension. A treatment process includes: conducting ultrasonic positioning measurement on both sides of perirenal fat tissue of a patient, setting a therapeutic window and parameters of the system, and setting corresponding power parameter of the system, so as to make local temperature of the tissue during treatment reach 40...
Methods and compositions for treating diabetes, metabolic syndrome and other conditions
Cortendo Ab (publ)
June 07, 2018 - N°20180153883

Pharmaceuticals compositions comprising the 2s, 4r, ketoconazole enantiomer or its pharmaceutically acceptable salts, hydrates, and solvates, that are substantially free of the 2r, 4s ketoconazole enantiomer are useful to reduce cortisol synthese and for the treatment of type 2 diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, metabolic syndrome, and other diseases and conditions, including but not limited to cushing's syndrome, ...
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
System and method for optogenetic therapy
Circuit Therapeutics, Inc.
May 24, 2018 - N°20180140862

Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations.
Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
Board Of Regents Of The University Of Nebraska
May 24, 2018 - N°20180140544

There is disclosed a method for administration of a formulation of resiniferatoxin (rtx) to provide cardiac sympathetic afferent denervation when applied in an amount and concentration sufficient to chemically denervate vanilloid 1 receptor (trpv1)-expressing csar (cardiac sympathetic afferent reflex) afferents. There is further disclosed a method for treating heart failure or hypertension and its related indications selected from the group ...
Multi-pole synchronous pulmonary artery radiofrequency ablation catheter
Pulnovo Medical (wuxi) Co., Ltd
May 24, 2018 - N°20180140347

A multi-pole synchronous pulmonary artery radiofrequency ablation catheter may comprise a control handle, a catheter body and an annular ring. One end of the catheter body may be flexible, and the flexible end of the catheter body may be connected to the annular ring.
Methods and systems for measuring plasma renin activity
Laboratory Corporation Of America Holdings
May 17, 2018 - N°20180134634

Disclosed are methods and systems for the quantification of angi and/or determination of plasma renin activity in a sample. The methods and systems disclosed herein can be useful for diagnosis of hypertension, aldosteronism and other abnormalities of the renin angiotensin aldosterone system (raas)..
System and method for optogenetic therapy
Circuit Therapeutics, Inc.
May 17, 2018 - N°20180133501

Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations.
Method and apparatus for controlling spinal cord stimulation to treat hypertension
Boston Scientific Neuromodulation Corporation
May 17, 2018 - N°20180133480

An example of a system for modulating blood pressure may include a blood pressure monitoring circuit, a blood pressure modulation device, and a control circuit. The blood pressure monitoring circuit may be configured to sense signals and generate one or more blood pressure parameters indicative of the blood pressure and/or a vascular resistance and one or more activity parameters ...
Compositions and methods for treating diabetes, hypertension and hypercholesterolemia
Imagine Pharma
May 17, 2018 - N°20180133280

The present invention provides a composition comprising a therapeutically effective amount of a polypeptide, peptide, or analog corresponding to one or more of seq id no(s) 1, 2, 3 or 4, and or more of a pharmaceutically acceptable carrier, pharmaceutically acceptable diluent, and/or pharmaceutically acceptable excipient. The polypeptide therapeutic of the present invention may be formulated for administration to a subject in ...
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compositions for the treatment of hypertension
The George Institute For Global Health
May 17, 2018 - N°20180133227

Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin ii receptor blocker, a diuretic, a calcium channel blocker, and a beta-blocker, wherein the dose of each component is below the lowest dose approved for the treatment of hypertension for the component.. .
Methods and compositions for treating pulmonary hypertension
Abraxis Bioscience, Llc
May 17, 2018 - N°20180133157

The present invention features methods for treating, stabilizing, preventing, and/or delaying pulmonary hypertension by administering nanoparticles that comprise rapamycin or a derivative thereof and/or nanoparticles that comprise a taxane (e.g., paclitaxel) or a derivative thereof. The invention also provides compositions (e.g., unit dosage forms) comprising nanoparticles that comprise a carrier protein and rapamycin or a derivative ...
A method for predicting the risk of incidence of chronic kidney diseases
Sphingotec Gmbh
May 10, 2018 - N°20180128838

The present invention relates to means and methods suitable for risk prediction of chronic kidney disease (ckd) using pro-enkephalin or fragments thereof as biomarker. The risk prediction methods of the invention are intended for healthy subjects and for subjects suffering from diseases such as hypertension, cardiovascular diseases and events, diabetes, metabolic syndrome, obesity, or autoimmune diseases.
Use of aptamers in therapy and/or diagnosis of autoimmune diseases
Max-delbrueck-centrum Fuer Molekulare Medizin
May 10, 2018 - N°20180127757

The present invention is directed to an aptamer comprising or consisting of the nucleic acid sequence of seq id no. 1, seq id no.
Compositions and methods of use for (pro)renin receptor antagonists
University Of Utah Research Foundation
May 10, 2018 - N°20180125922

Disclosed are methods of treating kidney disease, infectious or inflammatory diseases, acute kidney injury and hypertension by administering a (pro)renin receptor (prr) antagonist. In some instances the prr antagonist is a polypeptide.
Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination ...
Volant Holdings Gmbh
May 10, 2018 - N°20180125870

The present invention is directed to pharmaceutical compositions and methods of treatment that relate to the inhibition, resolution and/or prevention of an array of the manifestations of metabolic syndromes, including type 2 diabetes, hyperlipidemia, weight gain, obesity, insulin resistance, hypertension, atherosclerosis, fatty liver diseases and certain chronic inflammatory states that lead to these manifestations, among others. In additional aspects, the ...
Methods for treating pulmonary hypertension
Reviva Pharmaceuticals, Inc.
May 10, 2018 - N°20180125851

The present invention provides a method of using arylpiperazine derivatives for treating pulmonary hypertension. The method comprises a step of administering to a patient in need thereof an effective amount of a compound of formula 1, which is an arylpiperazine derivative..
Methods and formulations for modulating lyn kinase activity and treating related disorders
Melior Pharmaceuticals I, Inc.
May 10, 2018 - N°20180125845

The present invention relates to compounds and pharmaceutically acceptable salts thereof and formulations comprising the compounds or a pharmaceutically acceptable salts thereof that are useful in modulating lyn kinase activity. In particular, the compounds or a pharmaceutically acceptable salts thereof are useful for treating or preventing a disease or disorder including cardiovascular disease, dyslipidemia, dyslipoproteinemia, a disorder of glucose metabolism, ...
Loading